Literature DB >> 14601649

Reduced IFN-gamma responses associated with HLA-DR15 presentation of streptococcal cell wall proteins to dermal Th-1 cells in psoriasis.

Barbara S Baker1, Jean-Marc Ovigne, Vincent A Fischetti, Anne Powles, Lionel Fry.   

Abstract

We have recently described a group A streptococcal (GAS)-reactive Th-1 subset specifically present in skin lesions of chronic plaque psoriasis. To investigate MHC presentation of GAS cell wall proteins, dermal T cell lines (TCL) cultured from the lesional skin of 39 HLA-typed psoriasis patients were stimulated with a cell wall extract, stained for intracellular IFN-gamma expression, and analyzed by flow cytometry. TCL from a further seven psoriasis patients were also tested with S. mutans extract. Eight TCL were tested in the presence of anti-Class II antibodies or allogeneic antigen-presenting cells. The dermal T cell IFN-gamma responses to the cell wall extract, which ranged from < 1 to 28%, were significantly higher than that to S. mutans extract (p = 0.0052) and were self-HLA-DR allele restricted. A significantly decreased response was observed in TCL from DR15+ (n = 13) versus DR15- (n = 26) patients (p = 0.0377). In addition, DR15+ patients had a later age of onset of disease and a decreased history of sore throats. In contrast, TCL from HLA-DR7+ (n = 23) patients responded similarly to those from individuals lacking the DR7 allele. However, DR7+ patients who coexpressed the MHC Class I antigen, Cw6 (n = 14) had a significantly higher IFN-gamma response than Cw6-, DR7+ patients (n = 7; p = 0.0288) whose responses were also significantly lower than those of patients expressing non-DR7 alleles (n = 16; p = 0.0302). This study has shown that HLA-DR15 expression is associated with a reduced dermal Th-1 response to GAS cell wall proteins in patients with psoriasis. It is proposed that HLA-DR allelic variation may contribute to disease phenotype via effects on the immune response to group A streptococci.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601649     DOI: 10.1023/a:1025377702283

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

1.  Non-M protein(s) on the cell wall and membrane of group A streptococci induce(s) IFN-gamma production by dermal CD4+ T cells in psoriasis.

Authors:  D W Brown; B S Baker; J M Ovigne; V A Fischetti; C Hardman; A V Powles; L Fry
Journal:  Arch Dermatol Res       Date:  2001-04       Impact factor: 3.017

2.  Infections and psoriasis; a preliminary communication.

Authors:  A NØRHOLM-PEDERSEN
Journal:  Acta Derm Venereol       Date:  1952       Impact factor: 4.437

3.  Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4.

Authors:  H Bachelez; B Flageul; L Dubertret; S Fraitag; R Grossman; N Brousse; D Poisson; R W Knowles; M C Wacholtz; T P Haverty; L Chatenoud; J F Bach
Journal:  J Autoimmun       Date:  1998-02       Impact factor: 7.094

4.  Clearance of psoriasis with low dose cyclosporin.

Authors:  C E Griffiths; A V Powles; J N Leonard; L Fry; B S Baker; H Valdimarsson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

5.  Lymphocyte activation by streptococcal antigens in psoriasis.

Authors:  W L Gross; U Packhäuser; G Hahn; E Westphal; E Christophers; M Schlaak
Journal:  Br J Dermatol       Date:  1977-11       Impact factor: 9.302

6.  Protein GRAB of streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin.

Authors:  M Rasmussen; H P Müller; L Björck
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

7.  Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study.

Authors:  A B Gottlieb; M Lebwohl; S Shirin; A Sherr; P Gilleaudeau; G Singer; G Solodkina; R Grossman; E Gisoldi; S Phillips; H M Neisler; J G Krueger
Journal:  J Am Acad Dermatol       Date:  2000-10       Impact factor: 11.527

8.  Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region.

Authors:  S Jenisch; T Henseler; R P Nair; S W Guo; E Westphal; P Stuart; M Krönke; J J Voorhees; E Christophers; J T Elder
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

9.  Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris.

Authors:  A Menssen; P Trommler; S Vollmer; D Schendel; E Albert; L Gürtler; G Riethmüller; J C Prinz
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

10.  A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity.

Authors:  V Pancholi; V A Fischetti
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  2 in total

1.  Peptidoglycan recognition proteins Pglyrp3 and Pglyrp4 are encoded from the epidermal differentiation complex and are candidate genes for the Psors4 locus on chromosome 1q21.

Authors:  Chao Sun; Punam Mathur; Josée Dupuis; Rich Tizard; Barry Ticho; Tom Crowell; Humphrey Gardner; Anne M Bowcock; John Carulli
Journal:  Hum Genet       Date:  2005-12-17       Impact factor: 4.132

2.  Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.

Authors:  Lynn D Haynes; Walker A Julliard; Joshua D Mezrich; Glen Leverson; Keith C Meyer; William J Burlingham
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.